Cleary Gottlieb Steen & Hamilton represented GSK, while Sullivan & Cromwell represented Boston Pharmaceuticals in the transaction.GSK announced its acquisition of Boston Pharmaceuticals’ lead asset efimosfermin…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
